David Tung

Dr. David Tung is an Associate Director of Translational Sciences at BioMed Valley Discoveries. With over 25 years of drug discovery experience, he is the lead for CMC, regulatory affairs, translational pharmacology, and clinical operations of the C. novyi-NT program. He also serves as the translational pharmacology lead for two antibody projects and is responsible for indications exploration for ERK and C. novyi-NT. Prior to BVD, he held positions at Pfizer, Sirna, Isis, Chiron (Novartis), and Celera. His translational pharmacology experience covers allergy and respiratory, osteo and rheumatoid arthritis, psoriasis, oncology, multiple sclerosis, stroke, traumatic brain injury, and fracture healing.

Dr. Tung received his PhD from UCSD’s Biomedical Engineering department. He completed his postdoctoral training in a joint fellowship at Parke-Davis Pharmaceutical and Department of Pathology, University of Michigan Medical School.